ONMETIO Trademark

Trademark Overview

On Friday, April 24, 2015, a trademark application was filed for ONMETIO with the United States Patent and Trademark Office. The USPTO has given the ONMETIO trademark a serial number of 79167522. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 23, 2022. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The ONMETIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for treating cancer and immune disorders; pharmaceutical preparations for treating cancer and immune disorders
onmetio

General Information

Serial Number79167522
Word MarkONMETIO
Filing DateFriday, April 24, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 23, 2022
Registration Number4911463
Registration DateTuesday, March 8, 2016
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 22, 2015

Trademark Statements

Description of MarkThe mark consists of the stylized wording "ONMETIO".
Goods and ServicesPharmaceutical compositions for treating cancer and immune disorders; pharmaceutical preparations for treating cancer and immune disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, July 21, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Sunday, June 25, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, June 25, 2023INVALIDATION PROCESSED
Tuesday, May 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 23, 2022CANCELLED SECTION 71
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 20, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 8, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 8, 2016REGISTERED-PRINCIPAL REGISTER
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 22, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 2, 2015NOTICE OF PUBLICATION
Monday, October 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 14, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 13, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 13, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 12, 2015REFUSAL PROCESSED BY IB
Friday, August 21, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 21, 2015REFUSAL PROCESSED BY MPU
Friday, August 21, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 20, 2015NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 20, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 22, 2015NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, July 21, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 20, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Tuesday, June 30, 2015APPLICATION FILING RECEIPT MAILED
Friday, June 26, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 25, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

onmetio immune disorders pharmaceutical cancer treating preparations compositions